<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03331497</url>
  </required_header>
  <id_info>
    <org_study_id>TT 50_2017</org_study_id>
    <nct_id>NCT03331497</nct_id>
  </id_info>
  <brief_title>Tonsillotomy or Follow-up in PFAPA Syndrome</brief_title>
  <official_title>Tonsillotomy or Follow-up in PFAPA -Syndrome - Randomised, Controlled Study Using Sequential Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tampere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) -syndrome
      diagnosis will be randomised either to tonsillotomy (partial tonsillectomy) or 3 months
      follow up. At follow up visit 3 months after randomisation the children from either groups
      with ongoing symptoms will be sent to tonsillectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) -syndrome
      diagnosis will be randomised either to tonsillotomy (partial tonsillectomy) or 3 months
      follow up.

      In both groups the symptoms are monitored with symptom diaries. At follow up visit 3 months
      after randomisation the children from either groups with ongoing symptoms will be sent to
      tonsillectomy (total remove of palatine tonsil).

      The design is sequential trial. From the previous trials we know that the effect of
      tonsillectomy is about 90% and that during follow up for six months as much as 50% of the
      patients will recover. Because the syndrome is rare and because the rescue operations of the
      tonsils (tonsillectomy in a person who has gone through tonsillotomy), the sample size has to
      be as low as possible. That is the reason why we chose sequential design, with assessments
      after every 8 patient.

      Randomization is made in blocks of four. In sequential design we use the following
      assumptions:

        -  We are looking for a 40% absolute difference in cure rate between tonsillotomy (90%) and
           follow up (50%) groups.

        -  Two sided Whitehead design

        -  Maximum likelihood estimation (MLE)

        -  Five assessments (sample size 4+4, 8+8. 12+12, 16+16 and 19+19)

        -  type 1 error 5 % and power 80%

        -  The sample size will be from 8 to 38 patients depending on when the trial can be stopped
           along assessments.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2017</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cure</measure>
    <time_frame>3 months from randomization</time_frame>
    <description>Proportion of patients who do not have any PFAPA symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rescue surgery</measure>
    <time_frame>12 months from randomization</time_frame>
    <description>Proportion of patients needing rescue surgery (tonsillectomy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with fever</measure>
    <time_frame>3 months from randomization</time_frame>
    <description>Number of days with fever &gt;38C in symptom diaries</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>PFAPA Syndrome</condition>
  <arm_group>
    <arm_group_label>Tonsillotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients diagnosed with PFAPA will have tonsillotomy performed in one month from randomisation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Follow up</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patients diagnosed with PFAPA will be monitored for 3 months time. If the symptoms still persist, tonsillectomy will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tonsillotomy</intervention_name>
    <description>About 2/3 of the palatine tonsil tissue is removed with coplator or bipolar knife.</description>
    <arm_group_label>Tonsillotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed PFAPA syndrome: regularly occurring fever episodes for 3-5 days for at least
             five times or for 6 months

        Exclusion Criteria:

          -  prior tonsil surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marjo Renko, prof</last_name>
    <phone>+358503878887</phone>
    <email>marjo.renko@oulu.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulla Lantto, MD</last_name>
    <email>ulla.lantto@ppshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oulu Unversity Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjo Renko, MD, PhD</last_name>
      <email>marjo.renko@oulu.fi</email>
    </contact>
    <contact_backup>
      <last_name>Terhi Tapiainen, MD, PhD</last_name>
      <email>terhi.tapiainen@oulu.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Marjo Renko, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Terhi Tapiainen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulla Lantto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elina Halme, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jarno Kujansivu, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2017</study_first_submitted>
  <study_first_submitted_qc>October 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

